Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06290869 · ClinicalTrials.gov registry record · Phase 3
Tobacco Education and Lung Health Study (TEAL)
A Phase 3 study of Smoking Cessation, sponsored by Georgetown University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 1,188
- Enrollment target
- 1
- Study location
NCT06290869 is a Phase 3 study of Smoking Cessation that is actively recruiting participants, run by Georgetown University. The registered enrollment target is 1,188 participants, above the 468-participant average among 188 other Smoking Cessation trials with a reported enrollment target (154% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06290869, a Phase 3 study of Smoking Cessation, is actively recruiting participants, sponsored by Georgetown University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 1,188 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary Objective To compare two smoking cessation interventions among individuals undergoing lung cancer screening. Primary outcomes are: 3-month self-reported abstinence from cigarettes and 6-month self-reported and bioverified abstinence from cigarettes. Secondary Objectives 1) To evaluate reach and engagement overall and by subgroup (e.g., race and ethnicity, underinsured, readiness to quit). 2) To conduct an economic analysis to evaluate intervention costs from the health system perspective.
Conditions Studied
Interventions
- BEHAVIORAL Phone-based Tobacco Treatment, Nicotine Replacement, and Stepped Care Intervention
- BEHAVIORAL E-Referral to the Tobacco Quitline
Study Locations (1)
District of Columbia
- Georgetown University Medical Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,188 participants |
| Start Date | 2024-02-22 |
| Est. Completion | 2028-03-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06290869
The ClinicalTrials.gov registry entry for NCT06290869 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 1,188 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 468-participant average among 188 other Smoking Cessation trials with a reported enrollment target (154% higher). The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which Phone-based Tobacco Treatment, Nicotine Replacement, and Stepped Care Intervention is the first listed.
NCT06290869 reports 1 study location spanning 1 distinct geographic area - top geographies include District of Columbia.
Frequently Asked Questions
What is clinical trial NCT06290869 about?
NCT06290869 is a clinical study titled "Tobacco Education and Lung Health Study (TEAL)". Primary Objective To compare two smoking cessation interventions among individuals undergoing lung cancer screening. Primary outcomes are: 3-month self-reported abstinence from cigarettes and 6-month self-reported and bioverified abstinence from cigarettes. Secondary Objectives 1) To evaluate reach...
What is the current status of trial NCT06290869?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 1,188 participants. The study started on 2024-02-22. Estimated completion is 2028-03-01.
What conditions does trial NCT06290869 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT06290869?
The interventions under investigation include: Phone-based Tobacco Treatment, Nicotine Replacement, and Stepped Care Intervention (BEHAVIORAL), E-Referral to the Tobacco Quitline (BEHAVIORAL).
Who is sponsoring clinical trial NCT06290869?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06290869 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
V+PSF-M for Tobacco Cessation in HIV Care in India
RECRUITING · Phase 3
-
Improving Smoking Abstinence Outcomes in the African American Community Through Extended Treatment
RECRUITING · Phase 3
-
Evaluation of a Tailored Smoking Cessation Treatment Algorithm Based on Initial Treatment Response and Genotype
COMPLETED · Phase 3
-
Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).
COMPLETED · Phase 3
-
Safety and Efficacy Study of Topiramate to Aid in Smoking Cessation
COMPLETED · Phase 3
-
Nicotine Mouth Film for Craving Relief.
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.